Sounds like a great drug, but it is not a Merck product. The drug was discovered and developed by OncoImmune.
---
Merck acquired MK-7110 when it made a deal last month to buy OncoImmune, the pharmaceutical firm behind the drug.
The treatment, originally named CD24Fc, uses something called...